Hydrogenology
Source-linked study record

Hydrogen gas and the gut microbiota are potential biomarkers for the development of experimental colitis in mice

Fujiki Y, Tanaka T, Yakabe K, Seki N, Akiyama M, Uchida K, Kim YG. · Gut Microbiome. 2023;5:e3.

PreclinicalOther formsPublished 2023Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Preclinical

Population or model

Six-week-old male C57BL/6J mice given dextran sulfate sodium (DSS) or non-sulfated dextran control.

Intervention and dose

No H₂ treatment was administered. Endogenously produced cage H₂ from breath, skin, flatus and feces was continuously sampled during colitis/control exposure. · H₂ was measured by sensor gas chromatography with a 1,000-ppb detection limit at an average sampling rate of about ten points/hour.

Duration

Fifteen days, with DSS/dextran on days 0–5 and repeated gas, weight, fecal LCN2 and microbiome measurements.

Reported result

Cage H₂ fell as DSS inflammation worsened and was negatively correlated with LCN2 and positively with body weight; H₂ AUC for the chosen LCN2 threshold was 0.75, lower than H₂S at 0.833. Several bacterial families correlated with H₂/inflammation. This was association only and did not test whether H₂ caused, prevented or treated colitis.

Main limitation

Small cage-level mouse experiment, repeated observations not independent animals, mixed breath/skin/fecal gas, observational correlations, selected biomarker threshold and no external validation. Japanese public grants funded the work; authors reported no conflicts.

Evidence and classification

What kind of evidence is this?

Evidence type

Preclinical

Reported design

Longitudinal mouse cage-biogas and microbiome observational experiment during DSS colitis

Research topic

Gastrointestinal health

Administration form

Other forms

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Six-week-old male C57BL/6J mice given dextran sulfate sodium (DSS) or non-sulfated dextran control.

Sample

Five mice per cage/group, monitored for 15 days; experiments were reported as independently repeated three times.

Duration

Fifteen days, with DSS/dextran on days 0–5 and repeated gas, weight, fecal LCN2 and microbiome measurements.

Intervention

No H₂ treatment was administered. Endogenously produced cage H₂ from breath, skin, flatus and feces was continuously sampled during colitis/control exposure.

Hydrogen form

Biologically generated endogenous H₂ — neither H₂-only therapy nor Brown's gas.

Dose or H₂ specification

H₂ was measured by sensor gas chromatography with a 1,000-ppb detection limit at an average sampling rate of about ten points/hour.

Comparator

2% DSS for five days versus 2% dextran control, followed by tap water and longitudinal within-group measurements.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Five cage biogases, body weight, fecal lipocalin-2, 16S microbiome composition, correlations and ROC AUC for experimental colitis.

Reported result

Cage H₂ fell as DSS inflammation worsened and was negatively correlated with LCN2 and positively with body weight; H₂ AUC for the chosen LCN2 threshold was 0.75, lower than H₂S at 0.833. Several bacterial families correlated with H₂/inflammation. This was association only and did not test whether H₂ caused, prevented or treated colitis.

Extraction completeness

The complete free PMC article, methods, figures and disclosures were checked for endogenous-versus-administered H₂, cage-level sampling, controls, sample/repeats, correlations/ROC, limitations, funding and conflicts.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Small cage-level mouse experiment, repeated observations not independent animals, mixed breath/skin/fecal gas, observational correlations, selected biomarker threshold and no external validation. Japanese public grants funded the work; authors reported no conflicts.

Applies directly to

Potential non-invasive biomarker in DSS mouse colitis; it does not validate a human IBD test or an H₂ treatment.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 39290658 · DOI: 10.1017/gmb.2023.17

Publisher access

Free full article in PubMed Central.

Extraction basis

Complete PMC article and PubMed metadata; full-text extraction checked 9 August 2026.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.